Skip to main content
Clinical Trials/IRCT20131020015083N5
IRCT20131020015083N5
Recruiting
Phase 3

Investigating the effect of injectable and topical Bupivacaine on post operative pain after rhinoplasty

Shiraz University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
patients underwent rhinoplasty.
Sponsor
Shiraz University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA I physical status based on the American Classification of Anesthesiology (ASA)
  • Age between 17 and 50 years
  • Performing primary rhinoplasty with standard technique and oblique lateral\-medial osteotomy

Exclusion Criteria

  • Not agreeing to participate in the study
  • Patients with cardiovascular disease
  • History of sensitivity to bupivacaine
  • Receiving other anesthetics before and during the operation
  • Cognitive disorders and the inability to communicate and express the level of pain

Outcomes

Primary Outcomes

Not specified

Similar Trials